Compare BNR & DFDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | DFDV |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.4M | 93.4M |
| IPO Year | 2019 | 2022 |
| Metric | BNR | DFDV |
|---|---|---|
| Price | $9.31 | $3.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | 4.2K | ★ 542.0K |
| Earning Date | 06-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,099,660.00 |
| Revenue This Year | $111.65 | $32.58 |
| Revenue Next Year | N/A | $23.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.82 |
| 52 Week Low | $6.79 | $2.44 |
| 52 Week High | $41.72 | $20.30 |
| Indicator | BNR | DFDV |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 58.08 |
| Support Level | $8.69 | $3.04 |
| Resistance Level | $10.00 | $3.35 |
| Average True Range (ATR) | 0.52 | 0.20 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 50.58 | 74.46 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
DeFi Development Corp is a U.S. company committed to building its treasury around Solana (SOL), a fast-growing blockchain infrastructure platform. This equity delivers shareholders tangible exposure to SOL price movement and staking rewards, making the firm a proxy for the Solana ecosystem. The treasury extends to running its own validator infrastructure, allowing DFDV to actively participate in and benefit from the Solana network expansion. The firm has two segments: Digital Asset Treasury ("Treasury") and Real Estate Platform ("Real Estate"). The company generates the majority of its revenue from the Treasury segment.